Study Subject Withdrawal Clause Samples
The Study Subject Withdrawal clause outlines the procedures and conditions under which a participant may be withdrawn from a clinical study. It typically details who has the authority to initiate withdrawal—such as the subject, investigator, or sponsor—and the steps that must be followed, including documentation and notification requirements. For example, a subject may be withdrawn due to adverse events, non-compliance, or at their own request. This clause ensures that the process for withdrawal is clear and consistent, protecting the rights and safety of study subjects while maintaining the integrity of the study data.
Study Subject Withdrawal. In the event a Study subject does not report for a scheduled follow-up visit, Institution and/or Principal Investigator shall contact the Study subject within ten (10) days after the date of the scheduled visit regarding the failure to keep the appointment. If a Study subject withdraws from the Study, Institution and Principal Investigator shall use reasonable measures to follow up with the Study subject in person or by telephone (if possible), otherwise by certified mail, to determine the reason for the discontinuance and complete the termination form.
Study Subject Withdrawal. If at any time during the Study, Institution, Investigator or Rigel reasonably conclude that any Study Subject should immediately be withdrawn from administration of the Study Drug, the Parties shall cooperate to safely withdraw such Study Subject.
Study Subject Withdrawal. In the event a Study subject does not report for a scheduled follow-up visit, Institution shall contact the Study subject within ten (10) days after the date of the scheduled visit regarding the failure to keep the appointment. If a Study subject withdraws from the Study, Institution and shall use reasonable measures to follow up with the Study subject in person or by telephone (if possible), otherwise by certified mail, to determine the reason for the discontinuance and complete the termination form. 6.4 V yradenie/Odstúpenie účastníka skúšania. Ak sa účastník skúšania nedostaví na plánovanú návštevu súvisiacu s ďalším sledovaním, inštitúcia bude kontaktovať účastníka skúšania do desiatich (10) dní od dátumu plánovanej návštevy a informuje ho o nedodržaní termínu. Ak účastník skúšania odstúpi od klinického skúšania, inštitúcia vynaloží primerané opatrenia na to, aby kontaktovala účastníka skúšania, a to osobne alebo telefonicky (podľa možností), alebo prostredníctvom doporučenej pošty, s cieľom zistiť dôvod prerušenia liečby a vyplniť formulár o ukončení.
Study Subject Withdrawal. In the event a Study subject does not report for a scheduled follow-up visit, Institution and/or Principal Investigator shall contact the Study subject within ten (10) days after the date of the scheduled visit regarding the failure to keep the appointment. If a Study subject withdraws from the Study, Institution and Principal Investigator shall use reasonable measures to follow up with the Study subject in person or by telephone (if possible), otherwise by certified mail, to determine the reason for the discontinuance and 6.4 Odstoupení subjektu studie. V případě, že se subjekt studie nedostaví k plánované kontrolní návštěvě, zdravotnické zařízení a/nebo hlavní zkoušející bude subjekt studie do deseti (10) dnů po datu plánované návštěvy kontaktovat ve věci nedodržení termínu návštěvy. Jestliže subjekt studie ze studie odstoupí, zdravotnické zařízení a hlavní zkoušející využijí přiměřených opatření pro následné kontaktování subjektu studie osobně nebo telefonicky (je-li to možné), v ostatních případech doporučenou poštou, a to za účelem zjištění complete the termination form. důvodu přerušení a vyplnění ▇▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇.
Study Subject Withdrawal